Possible adverse effects of immunotherapy in non-small cell lung cancer; treatment and follow-up of three cases

In the past decade novel agents are on the market for non-small cell lung cancer adenocarcinoma based on pharmacogenomics. The epidermal growth factor receptor mutation, anaplastic lymphoma kinase and programmed death-ligand 1 investigation is necessary in the everyday clinical practice for the onco...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Respir Med Case Rep
Main Authors: Zarogoulidis, Paul, Chinelis, Panos, Athanasiadou, Anastasia, Tsiouda, Theodora, Trakada, Georgia, Kallianos, Anastasios, Veletza, Lemonia, Hatzibougias, Dimitris, Mihalopoulou, Electra, Goupou, Eirini, Kosmidis, Christoforos, Sardeli, Chrysanthi, Huang, Haidong, Hohenforst-Schmidt, Wolfgang
Formato: Artigo
Idioma:Inglês
Publicado em: Elsevier 2017
Assuntos:
Case Report
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5519224/
https://ncbi.nlm.nih.gov/pubmed/28752057
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.rmcr.2017.07.004
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados